Stay updated on Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.5 to v3.6.6, reflecting an incremental update to the page’s content/template managed by the site. This change signals a maintenance update and does not modify the study data or key details presented on the page.
    Difference
    0.1%
    Check dated 2026-08-29T19:16:41.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    The page now displays a new revision tag, v3.6.5, replacing the previous v3.6.4 revision tag.
    Difference
    0.0%
    Check dated 2026-08-08T17:02:02.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.3 to v3.6.4, indicating a small version update to the page/template. This reflects a backend/content management update rather than a user-facing content change.
    Difference
    0.0%
    Check dated 2026-07-25T07:47:07.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.2 to v3.6.3, indicating a software/content management update. The study details and visible content appear unchanged.
    Difference
    0.0%
    Check dated 2026-07-03T22:21:04.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    The page revision metadata was updated from v3.6.0 to v3.6.2, indicating a newer version of the page. This update represents a minor documentation revision and does not alter study details, eligibility criteria, or outcomes.
    Difference
    0.0%
    Check dated 2026-06-27T00:02:01.000Z thumbnail image
  9. Check
    96 days ago
    Change Detected
    Summary
    The page introduces new user-help sections and explicitly states recruitment changes, and it also includes a formatting update to the Intervention/Treatment label along with a Revision: v3.6.0 tag.
    Difference
    0.4%
    Check dated 2026-06-12T16:44:01.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page.